CurveBeam AI (ASX:CVB) ROE % Adjusted to Book Value: -57.23% (As of Dec. 2025)


What is CurveBeam AI ROE % Adjusted to Book Value?

CurveBeam AI ASX:CVB ROE % Adjusted to Book Value is -57.23% as of Dec. 2025. The stock has 5 warning signs investors should review.

CurveBeam AI's ROE % for the quarter that ended in Dec. 2025 was -54.94%. CurveBeam AI's PB Ratio for the quarter that ended in Dec. 2025 was 0.96. CurveBeam AI's ROE % Adjusted to Book Value for the quarter that ended in Dec. 2025 was -57.23%.

CurveBeam AI ROE % Adjusted to Book Value Related Terms

CurveBeam AI ROE % Adjusted to Book Value Historical Data

* Premium members only.

The historical data trend for CurveBeam AI's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

CurveBeam AI ROE % Adjusted to Book Value Chart

CurveBeam AI Annual Data
Trend Jun21 Jun22 Jun23 Jun24 Jun25
ROE % Adjusted to Book Value
0.00 0.00 0.00 0.00 -53.53

CurveBeam AI Semi-Annual Data
Jun21 Dec21 Jun22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
ROE % Adjusted to Book Value Get a 7-Day Free Trial Premium Member Only 0.00 -31.78 -40.92 -39.21 -57.23

ASX:CVB vs ABT, SYK, MDT: ROE % Adjusted to Book Value Comparison

For the Medical Devices subindustry, CurveBeam AI's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

CurveBeam AI ROE % Adjusted to Book Value vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, CurveBeam AI's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where CurveBeam AI's ROE % Adjusted to Book Value falls into.


CurveBeam AI ROE % Adjusted to Book Value Calculation

CurveBeam AI's ROE % Adjusted to Book Value for the fiscal year that ended in Jun. 2025 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=-45.50% / 0.85
=-53.53%

CurveBeam AI's ROE % Adjusted to Book Value for the quarter that ended in Dec. 2025 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=-54.94% / 0.96
=-57.23%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a ROE % Adjusted to Book Value of -57.23% mean?
CurveBeam AI (ASX:CVB) has a ROE % Adjusted to Book Value of -57.23% as of Dec. 2025. Return on equity adjusted to book is the ratio of return on equity to price-book ratio. View historical data on CurveBeam AI and its competitors.
Is CurveBeam AI's ROE % Adjusted to Book Value too high?
CurveBeam AI's current ROE % Adjusted to Book Value is -57.23%.
How does CurveBeam AI's ROE % Adjusted to Book Value compare to ABT and SYK?
CurveBeam AI's ROE % Adjusted to Book Value of -57.23% can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROE % Adjusted to Book Value for a Medical Devices & Instruments company?
A good ROE % Adjusted to Book Value depends on the Medical Devices & Instruments industry context. However, ROE % Adjusted to Book Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROE % Adjusted to Book Value mean?
A high ROE % Adjusted to Book Value can signal that a stock is expensive relative to its fundamentals. Return on equity adjusted to book is the ratio of return on equity to price-book ratio. View historical data on CurveBeam AI and its competitors. CurveBeam AI's current ROE % Adjusted to Book Value is -57.23%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is CurveBeam AI stock overvalued right now?
CurveBeam AI (ASX:CVB) has a current ROE % Adjusted to Book Value of -57.23%. The current ROE % Adjusted to Book Value is -57.23%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROE % Adjusted to Book Value calculated?
ROE % Adjusted to Book Value is calculated from a company's financial statements. For CurveBeam AI (ASX:CVB), the current ROE % Adjusted to Book Value is -57.23% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

CurveBeam AI Business Description

Address 10 Queen Street, Level 10, Melbourne, VIC, AUS, 3000
CurveBeam AI Ltd is a manufacturer of specialized imaging equipment that has developed software that, through the use of artificial intelligence (AI), and deep learning AI (DLAI), automates the scan processing and analysis of the high-quality images produced from the company's CT devices to assist in the clinical assessment. The company has one operating segment, being the research, design, manufacture and sale of cone beam CT imaging equipment for orthopaedic specialties, which includes the development, validation and preparation for commercialisation of a HRpQCT Medical Device and Software as a Service (SaaS) platform.